These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 20061417)

  • 1. Nuclear factor-{kappa}B contributes to anaplastic thyroid carcinomas through up-regulation of miR-146a.
    Pacifico F; Crescenzi E; Mellone S; Iannetti A; Porrino N; Liguoro D; Moscato F; Grieco M; Formisano S; Leonardi A
    J Clin Endocrinol Metab; 2010 Mar; 95(3):1421-30. PubMed ID: 20061417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-146a targets PRKCE to modulate papillary thyroid tumor development.
    Zhang X; Li D; Li M; Ye M; Ding L; Cai H; Fu D; Lv Z
    Int J Cancer; 2014 Jan; 134(2):257-67. PubMed ID: 23457043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RbAp48 is a target of nuclear factor-kappaB activity in thyroid cancer.
    Pacifico F; Paolillo M; Chiappetta G; Crescenzi E; Arena S; Scaloni A; Monaco M; Vascotto C; Tell G; Formisano S; Leonardi A
    J Clin Endocrinol Metab; 2007 Apr; 92(4):1458-66. PubMed ID: 17244783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-146a modulates B-cell oncogenesis by regulating Egr1.
    Contreras JR; Palanichamy JK; Tran TM; Fernando TR; Rodriguez-Malave NI; Goswami N; Arboleda VA; Casero D; Rao DS
    Oncotarget; 2015 May; 6(13):11023-37. PubMed ID: 25906746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncogenic role of miR-17-92 cluster in anaplastic thyroid cancer cells.
    Takakura S; Mitsutake N; Nakashima M; Namba H; Saenko VA; Rogounovitch TI; Nakazawa Y; Hayashi T; Ohtsuru A; Yamashita S
    Cancer Sci; 2008 Jun; 99(6):1147-54. PubMed ID: 18429962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of the MIR155 host gene in physiological and pathological processes.
    Elton TS; Selemon H; Elton SM; Parinandi NL
    Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-146a alleviates chronic skin inflammation in atopic dermatitis through suppression of innate immune responses in keratinocytes.
    Rebane A; Runnel T; Aab A; Maslovskaja J; Rückert B; Zimmermann M; Plaas M; Kärner J; Treis A; Pihlap M; Haljasorg U; Hermann H; Nagy N; Kemeny L; Erm T; Kingo K; Li M; Boldin MP; Akdis CA
    J Allergy Clin Immunol; 2014 Oct; 134(4):836-847.e11. PubMed ID: 24996260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A limited set of human MicroRNA is deregulated in follicular thyroid carcinoma.
    Weber F; Teresi RE; Broelsch CE; Frilling A; Eng C
    J Clin Endocrinol Metab; 2006 Sep; 91(9):3584-91. PubMed ID: 16822819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A 4-MicroRNA signature can discriminate primary lymphomas from anaplastic carcinomas in thyroid cytology smears.
    Fassina A; Cappellesso R; Simonato F; Siri M; Ventura L; Tosato F; Busund LT; Pelizzo MR; Fassan M
    Cancer Cytopathol; 2014 Apr; 122(4):274-81. PubMed ID: 24327568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-146a and miR-146b in the diagnosis and prognosis of papillary thyroid carcinoma.
    Qiu Z; Li H; Wang J; Sun C
    Oncol Rep; 2017 Nov; 38(5):2735-2740. PubMed ID: 29048684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FOXP3 Controls an miR-146/NF-κB Negative Feedback Loop That Inhibits Apoptosis in Breast Cancer Cells.
    Liu R; Liu C; Chen D; Yang WH; Liu X; Liu CG; Dugas CM; Tang F; Zheng P; Liu Y; Wang L
    Cancer Res; 2015 Apr; 75(8):1703-13. PubMed ID: 25712342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-182 promotes cancer invasion by linking RET oncogene activated NF-κB to loss of the HES1/Notch1 regulatory circuit.
    Spitschak A; Meier C; Kowtharapu B; Engelmann D; Pützer BM
    Mol Cancer; 2017 Jan; 16(1):24. PubMed ID: 28122586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-96 plays an oncogenic role by targeting FOXO1 and regulating AKT/FOXO1/Bim pathway in papillary thyroid carcinoma cells.
    Song HM; Luo Y; Li DF; Wei CK; Hua KY; Song JL; Xu H; Maskey N; Fang L
    Int J Clin Exp Pathol; 2015; 8(9):9889-900. PubMed ID: 26617698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-146a protects small intestine against ischemia/reperfusion injury by down-regulating TLR4/TRAF6/NF-κB pathway.
    He X; Zheng Y; Liu S; Shi S; Liu Y; He Y; Zhang C; Zhou X
    J Cell Physiol; 2018 Mar; 233(3):2476-2488. PubMed ID: 28771774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TRAIL-induced miR-146a expression suppresses CXCR4-mediated human breast cancer migration.
    Wang D; Liu D; Gao J; Liu M; Liu S; Jiang M; Liu Y; Zheng D
    FEBS J; 2013 Jul; 280(14):3340-53. PubMed ID: 23647548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA deregulation in human thyroid papillary carcinomas.
    Pallante P; Visone R; Ferracin M; Ferraro A; Berlingieri MT; Troncone G; Chiappetta G; Liu CG; Santoro M; Negrini M; Croce CM; Fusco A
    Endocr Relat Cancer; 2006 Jun; 13(2):497-508. PubMed ID: 16728577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of miR-138 sustains NF-κB activation and promotes lipid raft formation in esophageal squamous cell carcinoma.
    Gong H; Song L; Lin C; Liu A; Lin X; Wu J; Li M; Li J
    Clin Cancer Res; 2013 Mar; 19(5):1083-93. PubMed ID: 23319823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptional regulation of microRNA-100, -146a, and -150 genes by p53 and NFκB p65/RelA in mouse striatal STHdh(Q7)/ Hdh(Q7) cells and human cervical carcinoma HeLa cells.
    Ghose J; Bhattacharyya NP
    RNA Biol; 2015; 12(4):457-77. PubMed ID: 25757558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-146a Ameliorates Inflammation via TRAF6/NF-κB Pathway in Intervertebral Disc Cells.
    Lv F; Huang Y; Lv W; Yang L; Li F; Fan J; Sun J
    Med Sci Monit; 2017 Feb; 23():659-664. PubMed ID: 28161709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-1 is a tumor suppressor in thyroid carcinogenesis targeting CCND2, CXCR4, and SDF-1alpha.
    Leone V; D'Angelo D; Rubio I; de Freitas PM; Federico A; Colamaio M; Pallante P; Medeiros-Neto G; Fusco A
    J Clin Endocrinol Metab; 2011 Sep; 96(9):E1388-98. PubMed ID: 21752897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.